463
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Psychometric validation of the depression and family functioning scale

, , , , , , & show all
Pages 639-650 | Received 31 Jul 2015, Accepted 16 Dec 2015, Published online: 25 Jan 2016

References

  • World Health Organization. Depression (fact sheet). 2012. Available at: http://www.who.int/mediacentre/factsheets/fs369/en/. Accessed August 18, 2014. Geneva, Switzerland
  • Burke L. The impact of maternal depression on familial relationships. Int Rev Psychiatry 2003;15:243–55.
  • Epstein NB, Baldwin LM, Bishop DS. The McMaster Family Assessment Device. J Marital Fam Ther 1983;9:171–80.
  • Hinchliffe M, Hooper D, Roberts FJ, et al. A study of the interaction between depressed patients and their spouses. Br J Psychiatry 1975;126:164–72.
  • Keitner GI, Miller IW. Family functioning and major depression: an overview. Am J Psychiatry 1990;147:1128–37.
  • Miller IW, Kabacoff RI, Epstein NB, et al. The development of a clinical rating scale for the McMaster Model of Family Functioning. Fam Process 1994;33:53–69.
  • Timko C, Cronkite RC, Swindle R, et al. Functioning status of adult children of depressed parents: a 23-year follow-up. Psychol Med 2008;38:343–52.
  • Weissman MM, Wickramaratne P, Nomura Y, et al. Offspring of depressed parents: 20 years later. Am J Psychiatry 2006;163:1001–8.
  • Weissman M, Payke E. The depressed woman: a study of her relationships. Chicago, IL: University of Chicago Press, 1974.
  • Kennedy N, Paykel ES. Residual symptoms at remission from depression: impact on long-term outcome. J Affect Disord 2004;80:135–44.
  • Israel JA. Remission in depression: definition and initial treatment approaches. J Psychopharmacol 2006;20(Suppl 3):5–10.
  • DiBenedetti DB, Danchenko N, Francois C, et al. Development of a family functioning scale for major depressive disorder. Curr Med Res Opin 2012;28:303–13.
  • European Medicines Agency (EMA). Committee for Medicinal Products for Human Use, Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of Medicinal products. London: EMA, 2005. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf. Accessed January 30, 2012.
  • Food and Drug Administration (FDA). Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed December 31, 2013 Silver Spring, MD, USA.
  • Haro JM, Chollet J, Boulenger JP, et al. Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM): design and characteristics of first 1000 patients. Pharmacoepidemiology Drug Safety 2013;22(Suppl 1):507.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text Revision (DSM-IV-TR). Arlington, VA: American Psychiatric Association, 2000.
  • Sheehan DV. The anxiety disease. New York: Scribner’s, 1983.
  • Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11(Suppl 3):89–95.
  • McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000;26:25–40.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606–13.
  • Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220–33.
  • Ware JE, Kosinski M, Keller S. SF-12: How to score the SF-12 Physical and Mental Health Summary Scales. 3rd ed. Lincoln, RI: Quality Metric, Inc., 1998.
  • Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353–65.
  • Reilly M. WPAI:GH/SHP English (US) 2.0. New York: Reilly Associates Inc, 2004. Available at: http://www.reillyassociates.net. Accessed September 29, 2011.
  • EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208.
  • Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia, PA: Lippincott-Raven Press, 1996:191–201.
  • Guy W. ECDEU assessment manual for psychopharmacology (United States Department of Health, Education, and Welfare Publication No. 76-338). Rockville, MD: National Institute of Mental Health, 1976:218–22.
  • Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382–9.
  • McDowell I, Newell C. Measuring health – a guide to rating scales and questionnaires, 2nd ed. New York: Oxford University Press, 1996.
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psych 1959;32:50–5.
  • Maier W, Buller R, Philipp M, et al. The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord 1988;14:61–8.
  • SAS Institute, Inc. SAS proprietary software, version 9.2. Cary NC: SAS Institute, Inc., 2008.
  • Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966;1:245–76.
  • Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas 1960;20:141–51.
  • Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297–334.
  • Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. 2nd ed. New York: Oxford University Press, 1995.
  • Schuck P. Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res 2004;13:571–86.
  • Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. McGraw-Hill: New York, 1994.
  • Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63:737–45.
  • Reeve BB, Wyrwich KW, Wu AW, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res 2013;22:1889–905.
  • Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status measures. J Clin Epidemiol 2007;60:34–42.
  • Lowe B, Unutzer J, Callahan CM, et al. Monitoring depression treatment outcomes with the Patient Health Questionnaire-9. Med Care 2004;42:1194–201.
  • Coles T, Coon C, DeMuro C, et al. Psychometric evaluation of the Sheehan Disability Scale in adult patients with ADHD. Neuropsychiatr Dis Treat 2014;10:887–95.
  • Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
  • Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;441:582–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.